The KRAS p.G12S mutation has been observed in thousands of patient tumors36, occurring in 2.8% of colorectal adenocarcinoma and 2.5% of nonsmall cell lung cancer37. The gene discussed is KRAS; the disease is colorectal adenocarcinoma.